Boniva

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

Lung CancerEsophageal CancerCirrhosisPostmenopausal OsteoporosisBone Disease

206 competitors in Lung Cancer

#DrugCompanyPhaseTrials

1

Keytruda

Merck & Co.

Phase 3

332

Imfinzi

AstraZeneca

Phase 3

253

Opdivo

Bristol-Myers Squibb

Phase 3

204

Tagrisso

AstraZeneca

Phase 3

195

Yervoy

Bristol-Myers Squibb

Phase 3

106

Boniva

CConrado Roberto Hoffmann Filho

Approved

17

Abraxane

Bristol-Myers Squibb

Phase 3

78

Imjudo

AstraZeneca

Phase 3

69

Tecentriq

Roche

Phase 3

610

Alunbrig

Takeda

Phase 3

4Show 33 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Osteoporosis26 trials

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Completed·Roche·Phase 4·NCT02604836·1,711 enrolled

A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

Completed·Roche·Phase 4·NCT00148915·98 enrolled

A Study of Adherence to Once Monthly Ibandronate (Bonviva) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)

Completed·Roche·Phase 4·NCT00545363·716 enrolled

Show 23 more trials

PRIOR Study - A Study of Ibandronate (Boniva) in Postmenopausal Women With Osteoporosis or Osteopenia

Completed·Roche·Phase 4·NCT02598453·545 enrolled

Efficacy of Oral Ibandronate in Osteoporosis

Unknown status·SShinshu University·Phase 2·NCT03186131·100 enrolled

Study Of The Efficacy And Security Of Ibandronate For Osteoporosis Treatment In A HIV-Infected Patients Cohort

Withdrawn·GGermans Trias i Pujol Hospital·Phase 4·NCT00662077

Study of Investigational Drug in Osteoporosis (MK-0217-908)

Completed·OOrganon and Co·Phase 3·NCT00092053·203 enrolled

The Effect Of Oral Ibandronate In Male Osteoporosis

Completed·Roche·Phase 3·NCT00397839·135 enrolled

A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

No longer available·Roche··NCT00493532

Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate

Completed·GSK·Phase 4·NCT00327990·300 enrolled

BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.

Completed·Roche·Phase 3·NCT00545779·677 enrolled

BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.

Completed·Roche·Phase 3·NCT00493623·68 enrolled

A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.

Completed·Roche·Phase 4·NCT00377234·356 enrolled

A Study of Ibandronate [Bonviva/Boniva] and Alendronate in Female Patients With Post-Menopausal Osteoporosis

Completed·Roche··NCT01128257·6,054 enrolled

A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)

Completed·Roche·Phase 4·NCT00303485·67 enrolled

A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.

Completed·Roche·Phase 4·NCT00503113·801 enrolled

MOBILE Study - A Study of Bonviva (Ibandronate) Regimens in Women With Post-Menopausal Osteoporosis

Completed·Roche·Phase 3·NCT00048061·1,609 enrolled

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Completed·Roche·Phase 3·NCT00048074·1,395 enrolled

ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.

Completed·Roche·Phase 4·NCT00545090·561 enrolled

A Study of Bonviva/Boniva (Ibandronate) in Biphosphonate-Naïve Women With Post-Menopausal Osteoporosis

Completed·Roche·Phase 3·NCT01290094·41 enrolled

BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis

Completed·Roche·Phase 4·NCT00545909·585 enrolled

SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.

Completed·Roche·Phase 4·NCT00545480·596 enrolled

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Completed·Roche·Phase 4·NCT00081653·719 enrolled

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Completed·Roche·Phase 4·NCT00551174·781 enrolled

A Study of Ibandronate (Bonviva) in Patients With Post-Menopausal Osteoporosis

Completed·Roche·Phase 4·NCT02598440·341 enrolled

A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.

Completed·Roche·Phase 4·NCT00545051·140 enrolled

Breast Cancer6 trials

A Study to Evaluate Renal Safety of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Disease Due to Breast Cancer

Completed·Roche·Phase 3·NCT02716792·334 enrolled

Study in Elderly Patients With Early Breast Cancer (ICE)

Completed·GGBG Forschungs GmbH·Phase 3·NCT00196859·1,500 enrolled

A Study to Assess the Short Term Efficacy of Intravenous Ibandronate (Bondronat) in Participants With Metastatic Bone Pain Due to Breast Cancer

Completed·Roche·Phase 4·NCT02553707·182 enrolled

Show 3 more trials

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.

Completed·Roche·Phase 2·NCT00502736·13 enrolled

A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.

Withdrawn·Roche·Phase 2·NCT00478270

S0308 Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone

Withdrawn·SSWOG Cancer Research Network·Phase 3·NCT00301886

Bone Disease4 trials

A Study of Ibandronate (Bondronat) in Participants With Malignant Bone Disease

Completed·Roche·Phase 3·NCT02561039·97 enrolled

A Study of Ibandronate (Bondronat) in Participants With Metastatic Bone Disease

Completed·Roche·Phase 4·NCT02564107·48 enrolled

A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease

Terminated·Roche·Phase 3·NCT00099203·163 enrolled

Show 1 more trial

A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain

Terminated·Roche·Phase 3·NCT00099177·96 enrolled

Osteopenia2 trials

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia

Completed·Roche·Phase 4·NCT00129623·160 enrolled

A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.

Completed·Roche·Phase 3·NCT00545207·150 enrolled

Postmenopausal Osteoporosis2 trials

Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis

Completed·GSK·Phase 4·NCT00405392·365 enrolled

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Completed·Roche·Phase 4·NCT02598934·308 enrolled

14 more indications

Cirrhosis1 trial

Efficacy and Safety of Oral Ibandronate in Patients of Liver Cirrhosis With Hepatic Osteodystrophy.

Unknown status·IInstitute of Liver and Biliary Sciences, India·N/A·NCT06022237·80 enrolled

Low Bone Mineral Density1 trial

The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density

Terminated·PPapageorgiou General Hospital·Phase 4·NCT00446589·19 enrolled

Esophageal Cancer1 trial

Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352)

Completed·OOrganon and Co··NCT01077817·684,815 enrolled

Osteonecrosis1 trial

Study Comparing Ibandronate Versus Placebo in Hip Osteonecrosis

Terminated·—·Phase 3·NCT02114489·8 enrolled

Postmenopausal Women1 trial

A Study to Evaluate the Safety and Efficacy of Denosumab and Ibandronate in Postmenopausal Women Sub-Optimally Treated With Daily or Weekly Bisphosphonates

Completed·Amgen·Phase 3·NCT00936897·833 enrolled

TIA1 trial

Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects

Completed·SSheffield Teaching Hospitals NHS Foundation Trust·Phase 2·NCT00666627·410 enrolled

Lung Cancer1 trial

Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis

Terminated·CChinese Society of Lung Cancer·Phase 4·NCT00492843·20 enrolled

Multiple Myeloma1 trial

Comparison of Ibandronate - Zoledronate Regarding Nephrotoxicity in Multiple Myeloma

Terminated·Roche·Phase 3·NCT02739594·89 enrolled

Oral1 trial

A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo

Completed·GSK·Phase 4·NCT02948881·100 enrolled

Bone Marrow Transplantation1 trial

Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients

Completed·MM.D. Anderson Cancer Center·Phase 3·NCT00824993·78 enrolled

Efficacy1 trial

Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids

Completed·YYeong-Wook Song·Phase 4·NCT01287533·167 enrolled

Renal Transplantation1 trial

Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.

Unknown status·SSmerud Medical Research International AS·Phase 2/3·NCT00423384·130 enrolled

Bone Density1 trial

Coral Calcium's Effect on Bone Density in Postmenopausal Women With and Without Ibandronate

Completed·—·Phase 2·NCT04321837·60 enrolled

Unspecified3 trials

PTH & Ibandronate Combination Study (PICS)

Completed·UUniversity of California, San Francisco·Phase 2/3·NCT00683163·44 enrolled

BONVIVA(Ibandronate) PMS(Post-marketing Surveillance )

Completed·GSK··NCT01381393·659 enrolled

Use of Ibandronate in Diabetic Patients

Completed·YYeouido St. Mary's Hospital·N/A·NCT05266261·121 enrolled

Regulatory

FDA Approval Timeline[4]

Details

Drug Info

Related News